David Meline

David Meline is recorded as Board Member at Pacific Biosciences Of California, Inc. (PACB) since June 18, 2024. Earlier roles on record: CFO at Moderna, Inc. (MRNA) until September 6, 2022. Pacific Biosciences Of California, Inc. reported in an 8-K filed January 30, 2025 that David Meline resigned as member of the Board, effective January 30, 2025. Pacific Biosciences Of California, Inc. reported in an 8-K filed June 20, 2024 that David Meline was appointed Class II Director, effective June 18, 2024. Pacific Biosciences Of California, Inc. reported in an 8-K filed October 16, 2023 that David Meline was appointed Class II director, effective October 13, 2023. Equibles holds 4 filed executive changes naming David Meline; each is listed under recent activity with its source filing. The proxy statement of Moderna, Inc. reports total compensation of $4,768,145 for David Meline in fiscal 2022, including a base salary of $426,497. Disclosed compensation is on record for 3 fiscal years. David Meline has spoken on 8 earnings calls across 1 company, most recently for Moderna, Inc. on August 3, 2022. Pacific Biosciences Of California, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls David Meline spoke on are classified in the Healthcare sector. Other leadership on record at Pacific Biosciences Of California, Inc. includes Christian Henry (CEO, CFO and Board Member), Mark Van Oene (CEO, CFO, COO and Board Member), Christian O. Henry (Chairman and Board Member) and 7 others.